Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
M SaitoT Matsuda

Abstract

The purpose of this pilot study was to determine the effect of recombinant hirudin (r-hirudin) on coagulopathy and the relationship between concentrations of thrombin-antithrombin III (ATIII) complex (TAT) and thrombin-hirudin complex (THC) in patients with disseminated intravascular coagulation (DIC). Five patients with haematological malignancy associated with DIC were studied. r-Hirudin was administered by continuous intravenous infusion at a dose of 0.005 mg/kg/h for 4-9 days to each patient. Fibrin/fibrinogen degradation products (FDP), D-dimer, TAT and plasmin-alpha 2 antiplasmin complex (PAP) concentrations decreased after treatment with r-hirudin in four patients studied. However, in one patient, serum creatinine increased to 1.7 mg/dl and aPTT was prolonged to 74.4s. Statistical analysis disclosed significant positive correlations between plasma concentrations of hirudin and THC, and between concentrations of THC and TAT. The concentrations of THC were much higher than those of TAT. In conclusion, these findings indicate that r-hirudin more strongly inhibited thrombin than did ATIII without heparin, and that administration of r-hirudin to renal insufficiency required individual adjustment of dosage. The present finding...Continue Reading

Citations

Jun 19, 2004·Hematology·Massimo Franchini, Franco Manzato
Mar 16, 1996·BMJ : British Medical Journal·T Baglin
Jan 31, 2003·Expert Opinion on Investigational Drugs·Vinay K Sharma, R Phillip Dellinger
Dec 18, 2001·Journal of Vascular Surgery·R G AlvaradoR M Zwolak
Oct 4, 2002·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·S Mukundan, Z R Zeigler
Jun 25, 2015·The Cochrane Database of Systematic Reviews·Arturo J Martí-CarvajalIvan Solà

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.